Companies Currently Raising

Industry key:

Life Sciences & Healthcare

Click on a Company’s name for contact information.

Develops & commercializes medical devices with integrated motion that improve patient outcomes.

An important new drug with clinical results superior to competitors to be “drug of choice” for the huge eczema market.

A precision diagnostics company focused on revolutionizing antibiotic sensitivity testing through its Jiddu Analyzer platform.

Coagulation Sciences is a blood testing innovator that will help blood banks and hospitals to significantly decrease blood transfusions.

Preventing permanent nerve damage, a devastating side effect of many chemo drugs.

Reaching for the “holy grail” of oral biologics with a first-in-class modality intended for gastrointestinal (GI)-related diseases including gut-health axis disorders.

At the forefront of a revolutionary holistic approach to the management of depression. Our mission is to harness the power of targeted nutrition to address the complex challenges of depression, offering hope and healing through scientifically advanced solutions.

ICaPath has developed a patented, novel and first in class immunotherapy solution based on PLGA nanoparticles.

i-Lumen Scientific™ is a retinal biotech company, pioneering a new field in ophthalmics, designed to improve eyesight in patients whose vision has been impaired by nonexudative (dry) age-related macular degeneration (dAMD).

Natáur's fermentation-based platform provides a cost-competitive, environmentally friendly alternative to the traditional petroleum supply chain for sulfur ingredients.

At Novel Microdevices, we are revolutionizing diagnostics with our Next-Gen, Patent-Protected Point-of-Care PCR Platform, delivering lab accuracy, rapid results, and unmatched affordability.

PredxBio is powering next-generation cancer therapeutics with AI-driven spatial biomarkers that delves into the mechanism of action of drugs and predicts the patient outcomes with over 90% accuracy.

Leverages its expertise in the design of brain penetrant medicines to create new therapies for brain diseases.